InMed Pharmaceuticals Inc

NASDAQ:INM  
1.46
-0.03 (-2.01%)
Earnings Announcements

InMed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results

Published: 11/10/2021 12:39 GMT
InMed Pharmaceuticals Inc (INM) - Inmed Pharmaceuticals Reports First Quarter Fiscal 2022 Financial Results and Provides Business Update.
Q1 Loss per Share $0.25.
Revenue is expected to be $0.13 Million
Adjusted EPS is expected to be -$0.24

Next Quarter Revenue Guidance is expected to be $0.43 Million
Next Quarter EPS Guidance is expected to be -$0.22

More details on our Analysts Page.